|
|
(20 intermediate revisions by the same user not shown) |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / Has Sectioning |
| + | |
| Property / Has Sectioning: Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |